Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Papillomavirus Infections × Injections × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Advanced Solid Tumor 21 Advanced Solid Tumors 19 Carcinoma, Non-Small-Cell Lung 15 Neoplasms 13 Solid Tumor 11 Prostatic Neoplasms 10 Multiple Myeloma 10 Recurrence 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Neoplasm Metastasis 8 Lymphoma, Large B-Cell, Diffuse 8 Stomach Neoplasms 7 Small Cell Lung Carcinoma 7 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Carcinoma, Hepatocellular 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Solid Tumors 5 Sarcoma 5 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Advanced Solid Tumour 5 Uterine Cervical Neoplasms 4 Myelodysplastic Syndromes 4 Head and Neck Neoplasms 4 Biliary Tract Neoplasms 4 Advanced Malignant Solid Tumor 4

Interventions

human papillomavirus vaccine, L1 type 16, 18 34 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 17 Papillomavirus Vaccines 16 Vaccines 10 Data Collection 9 Vaccines, Synthetic 4 Blood Specimen Collection 4 artesunic acid 3 artemisinin 3 Engerix-B 3 halofantrine 2 artenimol 2 Hepatitis A Vaccines 2 GX-188 vaccine 2 Colposcopy 2 ranpirnase 1 fludarabine 1 epigallocatechin gallate 1 Viusid 1 Vitamin B 12 1 VP-102 1 VGX-3100 1 Therapies, Investigational 1 Sodium Chloride 1 Pentetic Acid 1 Observation 1 Methods 1 Measles-Mumps-Rubella Vaccine 1 Interleukin-2 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡